Citigroup »

Crinetics Pharmaceuticals In shares owned by Citigroup

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Citigroup

Quarter filed Position value Share count Share price at filing
2024-03-31 $12M 248k 46.81
2023-12-31 $3.6M 102k 35.60
2023-09-30 $2.5M 84k 29.50
2023-03-31 $1.7M 104k 16.06
2022-12-31 $894k 49k 18.30
2022-09-30 $1.4M 71k 19.64
2021-12-31 $1.5M 52k 28.42
2021-03-31 $43k 2.8k 15.32
2020-12-31 $145k 10k 14.13
2020-09-30 $78k 5.0k 15.58
2020-06-30 $115k 6.6k 17.50
2020-03-31 $47k 3.2k 14.61
2019-12-31 $56k 2.3k 24.88
2019-09-30 $19k 1.2k 16.39
2019-06-30 $92k 3.6k 25.19
2019-03-31 $61k 2.7k 22.63
2018-12-31 $44k 1.5k 29.33
2018-09-30 $56k 1.9k 28.78